Home > News > Neurim Pharmaceuticals licenses Circadin®, a drug approved for the treatment of primary insomnia, to Lundbeck
Dr. Zach Pearl
Sign up to our newsletter and we will keep you updated with interesting articles about sleep and sleep disorders:
I'm a Healthcare Professional
Accept Terms & Conditions.
Sign up to receive free articles about sleep:
This website is intended to provide qualified Healthcare Professionals (HCPs) with information and support on insomnia management. This website contains promotional information.
Copyright © Neurim Pharmaceuticals, Inc. All rights reserved.